Welcome! For price inquiries, please feel free to contact us through the form on the right side. We will get back to you as soon as possible.
Creative Biostructure has long been focused on the research related to disease. We offer comprehensive analytical services for exosome lipidomics and metabolomics, which support you to find potential biomarkers much easier.
The Importance of Exosome Lipidomics & Metabolomics Analysis
Exosomes contain various compositions, including proteins, nucleic acids, lipids, and other metabolites, which facilitating cell-to-cell communication. In vivo cells, lipids usually act as medium for signal transduction. More importantly, exosomes contain several unique lipids compared with recipient cells, which may be used as novel biomarkers for disease diagnosis and prognosis. In addition to lipids, exosomes also carry a wide range of other metabolites that take an active role in cancer progression and can also be used for biomarker discovery. Therefore, the monitoring of exosome lipidomics and metabolomics is important to study the onset and progression of metabolic diseases. Given that lipid and metabolite contents of exosomes differ from the parent cells and also change during physiological processes, characterizing lipidomics of different biofluids is the most possible way to find out the sensitive and specific biomarkers.
Exosome Lipidomics & Metabolomics service
Creative Biostructure supports accurate and sensitive detection of metabolites from exosomes, which facilitates the exploration of biomarker screening. We have specialized experts and well-established platforms that allow getting the most information from your exosomes quickly and efficiently. Advantages of our exosome lipidomics and metabolomics service are as follows:
Figure 1 Characterization of the metabolite content of human plasma Exosome-Like Vesicles (P ELVs) (Panel A) or PANC 1 cell culture media (CCM ELVs) (Panel B). (Altadill et al., 2016)
Creative Biostructure focuses on cost-effective, high throughput biomarker development of diseases. We hope our work could add value to clinical and translational studies. We will continue to develop innovative ways to meet your requirements in biomarker discovery areas. Please feel free to contact us for more details and find out how it helps your research.